Patents by Inventor Toru Kondo

Toru Kondo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11984924
    Abstract: A transmit/receive module includes plural duplexers, a power amplifier, and a sending transmission line. The plural duplexers operate in bands different from each other and each includes a transmit filter and a receive filter. The power amplifier amplifies signals of pass bands of the plural transmit filters and outputs the amplified signals. The sending transmission line is connected to the plural transmit filters. The signals of the pass bands of the plural transmit filters output from the power amplifier are transmitted through the sending transmission line.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: May 14, 2024
    Assignee: MURATA MANUFACTURING CO., LTD.
    Inventors: Seima Kondo, Satoshi Tanaka, Satoshi Arayashiki, Hiroyuki Furusato, Jin Yokoyama, Toru Yamaji, Akio Kaneda, Kiwamu Sakano, Junichi Yoshioka, Tatsuya Tsujiguchi, Atushi Ono
  • Publication number: 20240125860
    Abstract: The objective of the present invention is to provide a technology capable of estimating a battery condition in conjunction with charging/discharging operations of a battery, without employing dedicated equipment for estimating the condition of the battery. A battery management device according to the present invention identifies a first period and a subsequent second period in a rest period after a battery finishes discharging or charging, and uses an output voltage difference in the second period to estimate the condition of the battery (see FIG. 1).
    Type: Application
    Filed: March 30, 2022
    Publication date: April 18, 2024
    Inventors: Emha Bayu MIFTAHULLATIF, Toru KOUNO, Hiroya FUJIMOTO, Yutaka UEDA, Katsutoshi KONDO
  • Patent number: 11939413
    Abstract: An acrylic resin powder soluble in acetone, including a multi-stage polymer (M) that includes a polymer (B) obtained by polymerizing a monomer mixture (b) containing methyl methacrylate and an alkyl (meth)acrylate ester (mb) in the presence of a polymer dispersion that contains a polymer (A) obtained by polymerizing a monomer mixture (a) containing an alkyl (meth)acrylate ester (ma), in which an alkyl group in the alkyl (meth)acrylate ester (ma) has 4 to 8 carbon atoms, an alkyl group in the alkyl (meth)acrylate ester (mb) has 4 to 8 carbon atoms, a glass transition temperature of the polymer (A) is 20° C. or lower, a glass transition temperature of the polymer (B) obtained by polymerizing the monomer mixture (b) is 55° C. or higher, and a mass average molecular weight of the multi-stage polymer (M) is 10,000 or more and 300,000 or less.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: March 26, 2024
    Assignee: Mitsubishi Chemical Corporation
    Inventors: Shogo Miyai, Toru Kondo
  • Publication number: 20220364065
    Abstract: An object is to provide a composition and a method for eliminating undifferentiated pluripotent stem cells remaining in a cell group induced to differentiate from pluripotent stem cells. It has been found that while dihydroorotate dehydrogenase inhibitors exhibit cytotoxic activity against pluripotent stem cells, they do not exhibit significant cytotoxic activity against differentiated cells such as somatic stem cells.
    Type: Application
    Filed: December 19, 2019
    Publication date: November 17, 2022
    Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventor: Toru KONDO
  • Publication number: 20220332842
    Abstract: In order to provide an antibody having high therapeutic and prophylactic effects against cancer and the like, three types of mouse monoclonal antibodies were prepared which exhibit high affinities for a human-derived Eva1 protein. Moreover, constant regions of these antibodies were substituted with human-derived constant regions to also prepare chimeric antibodies. Further, these mouse antibodies and chimeric antibodies were found to have high ADCC and/or CDC activities. Furthermore, it was also revealed that administering these antibodies to mice having been subjected to melanoma cell administration suppresses the metastasis and the like of the cells to the lungs.
    Type: Application
    Filed: April 25, 2022
    Publication date: October 20, 2022
    Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Toshitada TAKEMORI, Mikako Shirouzu, Miho Tanaka, Tamami Ueshima, Toru Kondo
  • Patent number: 11415703
    Abstract: A GNSS receiver has a first antenna and a reference antenna. From the measurement of a carrier phase L1k of GNSS signals at the first antenna and a reference carrier phase L0k at the reference antenna, a single difference L10k is obtained, whereby calculating a double difference L10k0=L10k?L100 between a k-th GNSS satellite and a reference satellite (k=0). The double difference L10k0 is also predicted using known satellite position information as a function of a differencing vector ek0 between a unit line-of-sight direction vector ek of the k-th satellite and that of the reference satellite e0 and a base line vector ? with a second integer bias N10k0. A real time kinematic (RTK) positioning solution is calculated with ambiguity resolution based on the predicted value of L10k0 and the calculated value of L10k0. A spoofing is detected if the RTK positioning solution yields ?=0.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: August 16, 2022
    Assignee: Magellan Systems Japan, Inc.
    Inventor: Toru Kondo
  • Patent number: 11339224
    Abstract: In order to provide an antibody having high therapeutic and prophylactic effects against cancer and the like, three types of mouse monoclonal antibodies were prepared which exhibit high affinities for a human-derived Eva1 protein. Moreover, constant regions of these antibodies were substituted with human-derived constant regions to also prepare chimeric antibodies. Further, these mouse antibodies and chimeric antibodies were found to have high ADCC and/or CDC activities. Furthermore, it was also revealed that administering these antibodies to mice having been subjected to melanoma cell administration suppresses the metastasis and the like of the cells to the lungs.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: May 24, 2022
    Assignee: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Toshitada Takemori, Mikako Shirouzu, Miho Tanaka, Tamami Ueshima, Toru Kondo
  • Publication number: 20220151548
    Abstract: This invention relates to the methods for the identification and isolation of cancer stem cells from cultured cancer cell lines. Cell line-derived cancer stem cells isolated using the present methods may be useful, for example, in assays to screen compounds for anti-cancer stem cell activity and in target discovery methods for identifying novel expressed genes and druggable targets. The invention also relates to the screening of compounds for activity against cell line-derived cancer stem cells.
    Type: Application
    Filed: November 25, 2019
    Publication date: May 19, 2022
    Applicant: Cambridge Enterprise Limited
    Inventor: Toru Kondo
  • Patent number: 11084896
    Abstract: There are provided an acrylic polymer and plastisol using which a textile ink having excellent washing resistance and crocking resistance can be produced and a textile ink having excellent washing resistance and crocking resistance. The acrylic polymer of the present invention is an acrylic polymer comprising an acetone-soluble portion (A) and an acetone-insoluble portion (B), and the content of the acetone-insoluble portion (B) in the acrylic polymer is 5 mass % to 29 mass %, and the content of methyl methacrylate units in the acetone-soluble portion (A) is 60 mass % to 85 mass %.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: August 10, 2021
    Assignee: Mitsubishi Chemical Corporation
    Inventors: Eriko Satou, Toru Kondo, Saki Fujita, Yuuta Maenaka
  • Publication number: 20210215829
    Abstract: A GNSS receiver has a first antenna and a reference antenna. From the measurement of a carrier phase L1k of GNSS signals at the first antenna and a reference carrier phase L0k at the reference antenna, a single difference L10k is obtained, whereby calculating a double difference L10k0=L10k?L100 between a k-th GNSS satellite and a reference satellite (k=0). The double difference L10k0 is also predicted using known satellite position information as a function of a differencing vector ek0 between a unit line-of-sight direction vector ek of the k-th satellite and that of the reference satellite eo and a base line vector ? with a second integer bias N10k0. A real time kinematic (RTK) positioning solution is calculated with ambiguity resolution based on the predicted value of L10k0 and the calculated value of L10k0. A spoofing is detected if the RTK positioning solution yields ?=0.
    Type: Application
    Filed: August 25, 2020
    Publication date: July 15, 2021
    Inventor: Toru KONDO
  • Publication number: 20210113540
    Abstract: An object of the present invention is to provide an effective treatment agent and a pharmaceutical composition for prevention or treatment of glioma. The present invention provides a glioma treatment agent which comprises a compound represented by formula (1) or a salt thereof.
    Type: Application
    Filed: June 6, 2019
    Publication date: April 22, 2021
    Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Yukiko ISHII, Toru KONDO
  • Patent number: 10937818
    Abstract: A solid-state imaging device includes a first semiconductor substrate including a pixel array unit, a second semiconductor substrate stacked on a surface of a side opposite to a side on which light is incident in the first semiconductor substrate and on which a pixel control circuit and a reading circuit are arranged, and a plurality of connection electrodes configured to electrically connect pixel control signal lines between the first semiconductor substrate and the second semiconductor substrate, wherein the connection electrodes electrically connect pixel control signal lines within a pixel immediate region which overlaps a region where the pixel array unit is arranged in the first semiconductor substrate, and the pixel control circuit is arranged along an edge of the pixels in either one of a row direction and a column direction arranged in the pixel array unit in the pixel immediate region.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: March 2, 2021
    Assignee: OLYMPUS CORPORATION
    Inventor: Toru Kondo
  • Publication number: 20210009868
    Abstract: An acrylic resin powder soluble in acetone, including a multi-stage polymer (M) that includes a polymer (B) obtained by polymerizing a monomer mixture (b) containing methyl methacrylate and an alkyl (meth)acrylate ester (mb) in the presence of a polymer dispersion that contains a polymer (A) obtained by polymerizing a monomer mixture (a) containing an alkyl (meth)acrylate ester (ma), in which an alkyl group in the alkyl (meth)acrylate ester (ma) has 4 to 8 carbon atoms, an alkyl group in the alkyl (meth)acrylate ester (mb) has 4 to 8 carbon atoms, a glass transition temperature of the polymer (A) is 20° C. or lower, a glass transition temperature of the polymer (B) obtained by polymerizing the monomer mixture (b) is 55° C. or higher, and a mass average molecular weight of the multi-stage polymer (M) is 10,000 or more and 300,000 or less.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 14, 2021
    Applicant: Mitsubishi Chemical Corporation
    Inventors: Shogo MIYAI, Toru KONDO
  • Publication number: 20200390385
    Abstract: This invention relates to the methods for the identification and isolation of cancer stem cells from cultured cancer cell lines. Cell line-derived cancer stem cells isolated using the present methods may be useful, for example, in assays to screen compounds for anti-cancer stem cell activity and in target discovery methods for identifying novel expressed genes and druggable targets. The invention also relates to the screening of compounds for activity against cell line-derived cancer stem cells.
    Type: Application
    Filed: November 25, 2019
    Publication date: December 17, 2020
    Applicant: Cambridge Enterprise Limited
    Inventor: Toru Kondo
  • Patent number: 10863132
    Abstract: A solid-state image pickup device includes: a pixel array in which a plurality of pixels each outputting a photoelectric conversion signal are disposed; a reference voltage generator that generates a temperature detection voltage changing in accordance with a change in temperature and a reference voltage not depending on a change in temperature; a read circuit that performs signal processing of the photoelectric conversion signal output by the pixel array and the temperature detection voltage generated by the reference voltage generator and reads the photoelectric conversion signal and the temperature detection voltage that are processed; an output circuit that outputs both the photoelectric conversion signal and the temperature detection voltage for which the signal processing has been performed by the read circuit to the outside; and a bias generator that supplies a bias voltage generated based on the reference voltage to both the read circuit and the output circuit.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: December 8, 2020
    Assignee: OLYMPUS CORPORATION
    Inventor: Toru Kondo
  • Publication number: 20200140589
    Abstract: There are provided an acrylic polymer and plastisol using which a textile ink having excellent washing resistance and crocking resistance can be produced and a textile ink having excellent washing resistance and crocking resistance. The acrylic polymer of the present invention is an acrylic polymer comprising an acetone-soluble portion (A) and an acetone-insoluble portion (B), and the content of the acetone-insoluble portion (B) in the acrylic polymer is 5 mass % to 29 mass %, and the content of methyl methacrylate units in the acetone-soluble portion (A) is 60 mass % to 85 mass %.
    Type: Application
    Filed: January 7, 2020
    Publication date: May 7, 2020
    Applicant: Mitsubishi Chemical Corporation
    Inventors: Eriko SATOU, Toru KONDO, Saki FUJITA, Yuuta MAENAKA
  • Patent number: 10538742
    Abstract: This invention relates to the methods for the identification and isolation of cancer stem cells from cultured cancer cell lines. Cell line-derived cancer stem cells isolated using the present methods may be useful, for example, in assays to screen compounds for anti-cancer stem cell activity and in target discovery methods for identifying novel expressed genes and druggable targets. The invention also relates to the screening of compounds for activity against cell line-derived cancer stem cells.
    Type: Grant
    Filed: November 12, 2005
    Date of Patent: January 21, 2020
    Assignee: Cambridge Enterprise Limited
    Inventor: Toru Kondo
  • Publication number: 20190268559
    Abstract: A solid-state image pickup device includes: a pixel array in which a plurality of pixels each outputting a photoelectric conversion signal are disposed; a reference voltage generator that generates a temperature detection voltage changing in accordance with a change in temperature and a reference voltage not depending on a change in temperature; a read circuit that performs signal processing of the photoelectric conversion signal output by the pixel array and the temperature detection voltage generated by the reference voltage generator and reads the photoelectric conversion signal and the temperature detection voltage that are processed; an output circuit that outputs both the photoelectric conversion signal and the temperature detection voltage for which the signal processing has been performed by the read circuit to the outside; and a bias generator that supplies a bias voltage generated based on the reference voltage to both the read circuit and the output circuit.
    Type: Application
    Filed: May 14, 2019
    Publication date: August 29, 2019
    Applicant: OLYMPUS CORPORATION
    Inventor: Toru Kondo
  • Publication number: 20190256610
    Abstract: In order to provide an antibody having high therapeutic and prophylactic effects against cancer and the like, three types of mouse monoclonal antibodies were prepared which exhibit high affinities for a human-derived Eva1 protein. Moreover, constant regions of these antibodies were substituted with human-derived constant regions to also prepare chimeric antibodies. Further, these mouse antibodies and chimeric antibodies were found to have high ADCC and/or CDC activities. Furthermore, it was also revealed that administering these antibodies to mice having been subjected to melanoma cell administration suppresses the metastasis and the like of the cells to the lungs.
    Type: Application
    Filed: July 29, 2016
    Publication date: August 22, 2019
    Applicant: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Toshitada TAKEMORI, Mikako SHIROUZU, Miho TANAKA, Tamami UESHIMA, Toru KONDO
  • Patent number: 10363724
    Abstract: A resin composition including an epoxy resin (A), a curing agent (B), and vinyl polymer particles (C), in which the contained amount of epoxy resin (a1) having a molecular weight of 100-480 is 30-90 parts by mass per 100 parts by mass of the epoxy resin (A), the contained amount of epoxy resin (a2) having a molecular weight of 2,000-40,000 is 10-70 parts by mass per 100 parts by mass of the epoxy resin (A), the contained amount of the vinyl polymer particles (C) is 2-30 parts by mass per 100 parts by mass of the epoxy resin (A), and the instantaneous maximum thickening value of the vinyl polymer particles obtained by the following method is 0.3-5.0 Pa·s/° C.
    Type: Grant
    Filed: October 14, 2015
    Date of Patent: July 30, 2019
    Assignee: Mitsubishi Chemical Corporation
    Inventors: Takuya Teranishi, Akira Oota, Masahiro Ichino, Toru Kondo